High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus (Q39829199)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus
scientific article

    Statements

    High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus (English)
    Aritaka Makino
    Takamitsu Nakamura
    Mitsumasa Hirano
    Yoshinobu Kitta
    Keita Sano
    Tsuyoshi Kobayashi
    Daisuke Fujioka
    Yukio Saito
    Kazuhiro Watanabe
    Yosuke Watanabe
    Ken-ichi Kawabata
    Jun-ei Obata
    Kiyotaka Kugiyama
    21 September 2010
    573-578

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit